Search

Your search keyword '"Ribi S"' showing total 60 results

Search Constraints

Start Over You searched for: "Ribi S" Remove constraint "Ribi S" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
60 results on '"Ribi S"'

Search Results

1. A Primary Telangiectatic Mandibular Osteosarcoma With Germ‐Line Malignancy‐Associated DNA Damage Repair Gene Polymorphisms: A Case Report.

Catalog

Books, media, physical & digital resources

3. The knockdown of lncRNA DLGAP1‐AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR‐451a/HK2 axis.

4. Multiomic integration reveals neuronal‐extracellular vesicle coordination of gliotic responses in degeneration.

7. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies.

8. On the origin and nature of nongenetic information in eumetazoans.

10. Molecular and immunohistochemical testing of bone tumours: review and update.

11. Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma.

12. Using CRL3BPM E3 ligase substrate recognition sites as tools to impact plant development and stress tolerance in Arabidopsis thaliana.

13. TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.

14. The landscape of genetic aberrations in myxofibrosarcoma.

15. First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors.

16. Advanced analytics on IV curves and electroluminescence images of photovoltaic modules using machine learning algorithms.

18. Leveraging homologous recombination repair deficiency in sarcoma.

19. Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics.

20. DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma.

21. The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies.

23. Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?

24. LINC01128 regulates the development of osteosarcoma by sponging miR‐299‐3p to mediate MMP2 expression and activating Wnt/β‐catenin signalling pathway.

25. Sarcoma treatment in the era of molecular medicine.

26. Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient‐derived osteosarcoma cells and synergizes with cisplatin and talazoparib.

27. Prospects for the involvement of cancer stem cells in the pathogenesis of osteosarcoma.

28. Light‐responsive microRNA miR‐211 targets Ezrin to modulate lysosomal biogenesis and retinal cell clearance.

29. Invited Review: Dysregulation of chromatin remodellers in paediatric brain tumours – SMARCB1 and beyond.

30. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.

31. Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.

34. Genetic and clonal dissection of osteosarcoma progression and lung metastasis.

35. Interactions between short and long noncoding RNAs.

38. Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.

39. Reversible HuR-micro RNA binding controls extracellular export of miR-122 and augments stress response.

40. CD5 expression is regulated during human T-cell activation by alternative polyadenylation, PTBP1, and miR-204.

41. The impact of microRNA gene regulation on the survival and function of mature cell types in the eye.

43. The bimodally expressed micro RNA miR-142 gates exit from pluripotency.

44. Rapid neurogenesis through transcriptional activation in human stem cells.

45. DICER1 is essential for survival of postmitotic rod photoreceptor cells in mice.

49. Biological pathways to adaptability - interactions between genome, epigenome, nervous system and environment for adaptive behavior.

50. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.